近日，重组带状疱疹疫苗在成都正式开打，为本地中老年人群提供了预防带状疱疹的新选择。带状疱疹是一种由水痘-带状疱疹病毒引起的疾病，常见于50岁以上人群，症状以剧烈疼痛和皮肤疱疹为主，可能引发长期神经痛等并发症。该疫苗采用重组蛋白技术，有效性强，需接种两剂，可显著降低发病风险及严重程度。成都多区接种点已开放预约，建议符合年龄条件的居民，尤其是有基础疾病或免疫力较低者，及时咨询社区卫生服务中心并接种，以提升健康保障。
The recombinant shingles vaccine has recently become available in Chengdu, offering a new preventive option for middle-aged and elderly residents. Shingles, caused by the varicella-zoster virus, primarily affects individuals over 50 and is characterized by painful rashes and potential long-term complications like neuralgia. Utilizing recombinant protein technology, the vaccine requires two doses and demonstrates high efficacy in reducing the risk and severity of the disease. Multiple vaccination sites across Chengdu are now accepting appointments. It is recommended that eligible individuals, particularly those with underlying health conditions or weakened immune systems, consult local community health centers to get vaccinated and enhance their health protection.
原创文章，作者：admin，如若转载，请注明出处：https://ktez.cn/24334.html